US Cannabis ETF MSOS Underperforms Compared to Canadian Peers
PorAinvest
martes, 24 de junio de 2025, 7:11 am ET1 min de lectura
IMCC--
On Wednesday, retail chatter around IM Cannabis Corp. surged after the company announced its request for voluntary delisting from the Canadian Securities Exchange (CSE). Shares of IM Cannabis surged 45.7% to close at $2.71 on Wednesday, before slipping slightly by 0.37% to $2.7 in after-hours trading [1]. This demonstrates the potential volatility and interest in the cannabis sector, which MSOS is seeking to capitalize on.
MSOS's underperformance can be attributed to its listing on Canadian OTC exchanges, which have lower liquidity and less market visibility compared to US exchanges. This has made it difficult for MSOS to attract investors and maintain a competitive edge in the market. By purchasing equities from the OTC markets, MSOS is attempting to increase its liquidity and improve its market presence.
However, the effectiveness of this strategy remains to be seen. The high costs and administrative demands associated with regulatory approvals for dual listings, as identified by IM Cannabis, are likely to be a significant challenge for MSOS [1]. Moreover, the company's focus on NASDAQ trading has shown promise in terms of liquidity and shareholder value, but MSOS must navigate the complexities of the OTC market to achieve similar results.
In the meantime, income-hungry investors are turning to innovative ETF strategies to secure higher yields. Exchange-traded funds (ETFs) with dividend yields of 12% or higher are gaining traction, offering a compelling way to boost monthly income [2]. While these ETFs sacrifice some growth potential for generous payouts, they provide a viable option for investors seeking consistent income in a volatile market.
In conclusion, MSOS's underperformance is a result of its listing on Canadian OTC exchanges, and its attempt to purchase equities from the OTC markets through swapping is a step towards addressing this issue. However, the success of this strategy remains uncertain, and MSOS must navigate the complexities of the OTC market to achieve its goals. Meanwhile, income-hungry investors are exploring innovative ETF strategies to secure higher yields.
References:
[1] https://in.investing.com/news/stock-market-news/retail-buzz-surges-as-im-cannabis-plans-canadian-exchange-delisting-investors-hope-for-near-100-rally-4852162
[2] https://www.barchart.com/story/news/32964849/3-etfs-with-dividend-yields-of-12-or-higher-for-your-income-portfolio
MSOS--
MSOS ETF underperforms compared to Canadian cannabis peers. As a solution, MSOS purchases equities from the OTC markets through swapping, but US operators cannot list on US exchanges and are listed on Canadian OTC exchanges. This has led to underperformance of MSOS compared to Canadian cannabis peers.
The MSOS ETF has been underperforming compared to its Canadian cannabis peers, prompting the company to explore alternative strategies. As a solution, MSOS has begun purchasing equities from the OTC markets through swapping. However, this strategy has its limitations, as US operators cannot list on US exchanges and are instead listed on Canadian OTC exchanges, leading to the underperformance of MSOS [1].On Wednesday, retail chatter around IM Cannabis Corp. surged after the company announced its request for voluntary delisting from the Canadian Securities Exchange (CSE). Shares of IM Cannabis surged 45.7% to close at $2.71 on Wednesday, before slipping slightly by 0.37% to $2.7 in after-hours trading [1]. This demonstrates the potential volatility and interest in the cannabis sector, which MSOS is seeking to capitalize on.
MSOS's underperformance can be attributed to its listing on Canadian OTC exchanges, which have lower liquidity and less market visibility compared to US exchanges. This has made it difficult for MSOS to attract investors and maintain a competitive edge in the market. By purchasing equities from the OTC markets, MSOS is attempting to increase its liquidity and improve its market presence.
However, the effectiveness of this strategy remains to be seen. The high costs and administrative demands associated with regulatory approvals for dual listings, as identified by IM Cannabis, are likely to be a significant challenge for MSOS [1]. Moreover, the company's focus on NASDAQ trading has shown promise in terms of liquidity and shareholder value, but MSOS must navigate the complexities of the OTC market to achieve similar results.
In the meantime, income-hungry investors are turning to innovative ETF strategies to secure higher yields. Exchange-traded funds (ETFs) with dividend yields of 12% or higher are gaining traction, offering a compelling way to boost monthly income [2]. While these ETFs sacrifice some growth potential for generous payouts, they provide a viable option for investors seeking consistent income in a volatile market.
In conclusion, MSOS's underperformance is a result of its listing on Canadian OTC exchanges, and its attempt to purchase equities from the OTC markets through swapping is a step towards addressing this issue. However, the success of this strategy remains uncertain, and MSOS must navigate the complexities of the OTC market to achieve its goals. Meanwhile, income-hungry investors are exploring innovative ETF strategies to secure higher yields.
References:
[1] https://in.investing.com/news/stock-market-news/retail-buzz-surges-as-im-cannabis-plans-canadian-exchange-delisting-investors-hope-for-near-100-rally-4852162
[2] https://www.barchart.com/story/news/32964849/3-etfs-with-dividend-yields-of-12-or-higher-for-your-income-portfolio

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios